🇺🇸 FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10967058

Foot-and-mouth disease vaccine

United States of America as represented by the Secretary of the Air Force · Granted Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10961261

Oxaborole analogs and uses thereof

The Government of the United States, as represented by the Secretaryof the Army · Granted Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10961283

Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10961298

Monoclonal antibodies for treatment of microbial infections

The Government of the United States, represented by the Secretary of the Army · Granted Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10961301

Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair

The United States Government represented by the Department of Veterans Affairs · Granted Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10960070

Prefusion coronavirus spike proteins and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10961200

Small molecule inhibitors of lactate dehydrogenase and methods of use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10953083

Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10953085

Genetically engineered Foot and Mouth Disease Virus and related proteins, polynucleotides,

THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF AGRICULTURE · Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10953026

N-acetyl mannosammine as a therapeutic agent

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10954492

Processes for production and purification of nucleic acid-containing compositions

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10954198

Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfoldi

United Kingdom Research and Innovation · Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10954228

1 H-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of use there

NATIONAL INSTITUTES OF HEALTH, UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES · Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10954291

Monoclonal antibodies that specifically bind to matrilin-3 and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10947277

Nucleic acids encoding zika virus-like particles and their use in zika virus vaccines and

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10946048

Use of gram negative species to treat atopic dermatitis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10946049

Use of gram negative species to treat atopic dermatitis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10946065

Methods of treating fungal infections

United States of America as represented by the Secretary of the Air Force · Granted Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10946047

Extracellular vesicles with enhanced potency

United Therapeutics Corporation · Granted Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10947177

Compounds and methods for delivery of prostacyclin analogs

United Therapeutics Corporation · Granted Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10941128

Thymoquinone derivatives for treatment of cancer

UNITED ARAB EMIRATES UNIVERSITY · Granted Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10940241

Formation of stable cartilage

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10940188

Compounds and methods for treatment and prevention of Flavivirus infection

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10941187

GLP-1, exendin-4, peptide analogs and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted